WASHINGTON, June 24 -- Sen. Maggie Hassan issued the following press release:
U.S. Senator Maggie Hassan (D-NH), Ranking Member of the Senate Finance Subcommittee on Health Care, pressed Health and Human Services Secretary Robert F. Kennedy Jr. for answers following reporting (https://www.statnews.com/2026/06/23/eli-lilly-unusual-weight-loss-drug-trial-compassionate-use-retatrutide-trump/?utm_campaign=twitter_organic&utm_medium=social&utm_source=twitter) that the Trump Administration bent the rules of a federal program to provide a highly sought-after weight-loss drug, still in clinical trials, to a single VIP, potentially for free, while millions of Americans struggle to afford their prescriptions.
The experimental drug was provided in A...